The plant-based ingredient developer's series D round was co-led by GV and backed by Louis Dreyfus Company and Emart.

Grupo Jacto subsidiary Tridon helped the agricultural data technology provider boost its overall funding to $38m./

Novo, Bristol Myers-Squibb and Merck Group scored exits as the fibrosis and cancer drug developer priced its shares in the middle of the IPO's range.

Sanofi Ventures and Children's Hospital Colorado have returned to back Q32 Bio, an immune regulation-focused university spinout that has now raised at least $106m to date.

Propel Dayton is a three-phase accelerator targeting pre-spinout concepts leveraging University of Dayton's intellectual property.

Kraft Heinz's corporate venturing subsidiary joined counterparts at existing investors Koch and Prologis to bring the logistics automation technology producer’s total funding to $118m.

4100 Group led an extension to the Stanford-StartX Fund-backed healthcare AI technology provider's latest round, which now stands at $30m.

4100 Group led an extension to the healthcare AI technology provider's latest round and was joined by several existing corporate investors.

The fitness and sleep tracker provider, an alumnus of Harvard Innovation Lab, was valued at $1.2bn in a round that took its total funding past $200m.

Turning Point Brands has supplied $15m for cannabinoid health product developer Dosist through a co-development and distribution pact.